Importantly, concomitant TrkB and BDNF expression has been demonstrated in melanoma specimens [45, 48], suggesting that the BDNF/TrkB pathway can support an autocrine loop of growth and progression in this tumor. The gene discussed is NTRK2; the disease is neoplasm.